2 minute read
PROGRAM AGENDA
Day 1 – Tuesday, May 16th, 2023
SRB Ted Couch Auditorium
Advertisement
4:00-5:00 PM
W. Jack Pledger Researcher of the Year lecture: Anna Giuliano, Ph.D.
“It takes a village: Concurrent innate and adaptive T cell responses cooperate with humoral immunity to spontaneously exert immune pressure against human ovarian cancer progression”
5:00-6:00 PM Reception in SRB Murphy
Day 2 – Wednesday, May 17th, 2023
USF Marshall Student Center
8:00-9:00 AM Registration, Breakfast & Poster Viewing in the Ballroom
9:00-9:10 AM
9:10-9:35 AM
Welcome, Ken Wright, PhD, ACD (Oval Theater)
Featured Poster Presentations - Session I (Oval Theater)
Moderator: Dr. Katarzyna Rejniak
Dr. Luis Aguirre “Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes”
Dr. Cherell Cottrell-Daniels “Associations of Cancer Treatment Status on Smoking Cessation Among Survivors of CIN or Cervical Cancer”
Dr. Ou Deng “PARP16 modulates MYC expression and susceptibility of Ewing’s Sarcoma cells to PARP1 inhibition”
Dr. Ammoren Dohm “Upfront Osimertinib Alone Versus Osimertinib and Radiotherapy for the Treatment of EGFR-positive NSCLC Brain Metastases: A Multi-institutional Series”
Dr. Thomas Dombrowski “Tumor-immune ecosystem dynamics exploration via a high-resolution agent-based model”
Dr. Saurabh Garg “The correlation of oncodriver expression with tumor infiltrating lymphocytes in triple negative breast cancer (TNBC)”
Dr. Rebecca Hesterberg “Aging dampens lymphoma-provoked phenotypic and epigenomic changes to the adaptive immune system”
Dr. Filip Ionescu “Fludarabine Exposure Impact on Safety and Efficacy of Idecabtagene Vicleucel in Relapsed/Refractory Multiple Myeloma”
9:35-10:00 AM
Featured Poster Presentations - Session II (Oval Theater)
Moderator: Dr. Gage Redler
Dr. Daria Miroshnychenko “Stroma-induced cancer cell proliferation accelerates tumor recovery between chemotherapy cycles”
Mostafa Nasr “PRDM16: A key switch enabling long term skeletal dormancy and survival in prostate cancer”
10:00-11:30 AM
11:30- 12:30 PM
12:00-1:30 PM
1:45-2:10 PM
Dr. Eleonora Pelle “A novel hormone-based anti-SSTR T-cell engager for the treatment of neuroendocrine tumors”
Dr. Jennifer Perone “Evaluation of an Intraoperative Critical Event (ICE) Team at a Major Cancer Center”
Dr. Marilena Tauro “Novel autophagy inhibitory strategies to treat multiple myeloma”
Malgorzata Tyczynska-Weh “Modeling selection for evolvability in the evolution of cancer therapy resistance”
Dr. Tomas Zelenka “Bcl11b is a bimodal switch between stem-like and effector Trm cells in infection and tumor”
Poster Session #1 (Ballroom) Odd numbered Posters
Lunch (Ballroom)
Poster Session #2 (Ballroom) Even Numbered Posters
Oral Presentations – Session I (Oval Theater)
Moderator: Dr. Russell Palm
Dr. Facundo Davaro “Impact of Surgical Margin & Extent of Lymphadenectomy on Oncologic Outcomes in Plasmacytoid Urothelial Carcinoma”
Dr. Chandler Gatenbee “VALIS: Virtual Alignment of pathoLogy Image Series”
Vincent Law “Development of Intrathecal Drug Delivery Platform to Cure Breast Cancer Leptomeningeal Disease by Dendritic Cell Immunotherapy in Preclinical Model”
Dr. Shelly Li “Effects of Social Isolation on Symptoms of Depression and Anxiety among Young Adult Cancer Survivors: The Mediating Role of Social Support”
Karnav Modi “Frailty and high-risk immuno-nutritional score are associated with inferior outcomes in patients with relapsed and refractory multiple myeloma treated with chimeric antigen receptor T-cells”
2:10-3:00 PM
Oral Presentations – Session II (Oval Theater)
Moderator: Dr. Evan Wuthrick
Dr. Thales Nepomuceno “A comprehensive analysis of BRCA1 frameshift variants leading to extended incorrect protein termini”
Alyssa Obermayer “Transcriptome analysis and machine learning identify therapeutic strategies for high-risk pediatric AML patients of the KMT2A-fusion subgroup”
Devesh Raizada “Age-induced chronic accumulation of cortisol drives therapy resistance in lung cancer”
Dr. Fnu Sathyanarayana Neelature “To define how the uvel melanoma-liver environment crosstalk shapes metastasis growth and therapeutic response”
Dr. Leticia Tordesillas “Biodistribution of zoledronate and effects on gamma delta PSCA-CAR T cells in a model of bone metastatic prostate cancer”
3:00-3:15 PM Awards and Closing Remarks, Dr. Jong Park & Dr. Evan Wuthrick (Oval Theater)
